The ASAM Criteria are the clinical standard that dictates placement in US addiction care. Here is a plain-language guide to the updated six dimensions, the new 4th Edition levels of care, and how to use them to advocate for an appropriate clinical fit.
Last reviewed: April 23, 2026 | Reading time: 11 min | Topic: Placement & advocacy
In this guide
- Why this matters
- What the ASAM Criteria do
- The six dimensions (4th Edition)
- The 4th Edition levels of care
- What the Criteria discourage
- The "Capable" tier as the clinical floor
- Recovery residences, carefully
- How to use the Criteria to advocate
Why this matters
If your family is trying to find treatment for someone you love, you have likely been handed a set of assumptions dressed up as clinical facts. "They need 28 days." "Residential is the gold standard." "They have to hit rock bottom." None of these are evidence-based defaults. They are program-specific practices that are out of step with published clinical standards.
That standard is the ASAM Criteria, the American Society of Addiction Medicine Criteria, now in its 4th Edition (2023).1 The Criteria are the most widely used set of guidelines in the United States for matching adult patients with substance use disorders (SUDs) to the appropriate level of care. They are utilized by licensed clinicians, managed-care reviewers, and state Medicaid programs. Understanding their mechanics is one of the most effective ways a family can advocate for care.
What the ASAM Criteria do
The Criteria answer one central question: Given the biopsychosocial presentation of this patient right now, what is the least intensive, safe, and effective level of care?
They deliver a level-of-care recommendation. That recommendation is then reassessed regularly as the patient's dimensional profile stabilizes or shifts. A patient might step down from Level 3.7 (Medically Managed Residential) to Level 2.1 (Intensive Outpatient), and eventually to Level 1.0 (Long-Term Remission Monitoring) based on clinical progress across active treatment days.
The six dimensions (4th Edition)
In the 4th Edition, ASAM completely restructured the dimensions to better separate objective clinical risks from patient preferences. A clinician scores the patient across these six areas to determine the "Dimensional Drivers" that dictate placement.
Dimension 1, Intoxication, Withdrawal, and Addiction Medications
What is the immediate medical risk of withdrawal, and does the patient need addiction medications? For alcohol and benzodiazepines, withdrawal can require acute medical management. For opioid use disorders, rapid access to medications for opioid use disorder (MOUD) like buprenorphine or methadone is critical. This dimension determines if the patient requires medically managed care.
Dimension 2, Biomedical Conditions
Are there physical health concerns, sleep issues, or pregnancy-related complications? Uncontrolled diabetes, liver disease, or chronic pain can necessitate a setting with integrated nursing or medical oversight.
Dimension 3, Psychiatric and Cognitive Conditions
What co-occurring mental health issues are present? This dimension assesses active psychiatric symptoms, persistent disability, cognitive functioning, and trauma-related needs. Active suicidality or severe psychosis shifts the placement into Co-Occurring Enhanced (COE) or medically managed psychiatric levels.
Dimension 4, Substance Use-Related Risks
What is the likelihood of the patient engaging in risky substance use or SUD-related behaviors if they are not in a supervised setting? If a patient lacks the insight, impulse control, or coping skills to avoid use that could lead to serious harm, the placement shifts toward a residential structure.
Dimension 5, Recovery Environment Interactions
How effectively can this patient function in their current environment? This assesses safety, social support networks, and cultural perceptions. A recovery environment infused with substance use, lacking in social support, or posing a direct threat to safety is frequently the primary driver for a residential or recovery housing recommendation.
Dimension 6, Person-Centered Considerations
What are the barriers to care, patient preferences, and the need for motivational enhancement? Note: Dimension 6 does not dictate the initial level of care recommendation. Instead, it is used collaboratively to determine what the patient is actually willing and able to engage in (e.g., navigating childcare, transportation, or readiness to change).
The 4th Edition levels of care
The 4th Edition reorganized the continuum of care to better reflect modern outpatient capabilities and integrate withdrawal management.
Level 1.0, Long-Term Remission Monitoring
Quarterly, low-intensity check-ups for individuals in sustained remission. This replaces vague "aftercare" with a structured framework for chronic disease management.
Level 1.5, Outpatient Therapy
Standard outpatient counseling and psychotherapy (less than 9 hours per week) for mild SUDs or patients in early remission.
Level 1.7, Medically Managed Outpatient Treatment
Physician-led outpatient care for low-intensity ambulatory withdrawal management and the initiation/titration of addiction medications. This acknowledges that withdrawal management frequently does not require an inpatient admission.
Level 2.1, Intensive Outpatient Treatment (IOP)
Nine to nineteen clinical hours per week. Patients continue to sleep at home, practice skills in their own environment, and engage in daily life. Research consistently demonstrates outcomes comparable to residential care for appropriately matched patients.2
Level 2.5, High-Intensity Outpatient Treatment (HIOP)
Twenty or more clinical hours per week. Formerly known as Partial Hospitalization (PHP), this level provides intensive daily clinical services and a therapeutic milieu while the patient returns home at night.
Level 2.7, Medically Managed Intensive Outpatient Treatment
Intensive outpatient services with extended on-site medical monitoring and nursing support.
Level 3.1, Clinically Managed Low-Intensity Residential Treatment
A 24-hour supportive environment providing 9 to 19 hours of clinical services per week. Patients often practice reintegration by working or attending school during the day.
Level 3.5, Clinically Managed High-Intensity Residential Treatment
What is traditionally viewed as "rehab." 24-hour supervision with a high-intensity therapeutic milieu and at least 20 hours of clinical programming per week for patients with severe functional impairments.
Level 3.7, Medically Managed Residential Treatment
A residential setting with 24-hour nursing and medical management for patients experiencing acute withdrawal or severe biomedical/psychiatric complications.
Level 4, Medically Managed Inpatient Treatment
Hospital-based acute care for the highest clinical acuity.
What the Criteria explicitly discourage
A number of historical practices are fundamentally incompatible with the 4th Edition standards:
- Menu-driven lengths of stay. Treatment duration must be driven by dimensional progress and active treatment days, not arbitrary passive calendar milestones like "28 days."
- Refusing MOUD access. Every level of care must support the continuation of FDA-approved addiction medications. Programs forcing patients to taper off buprenorphine or methadone as a condition of admission are violating the clinical standard.
- Addiction-Only Services (AOS). Failing to address co-occurring mental health conditions is no longer acceptable.
The "Capable" tier as the clinical floor
Because co-occurring mental health conditions (like depression, anxiety, PTSD, or bipolar disorder) are the expectation rather than the exception, the ASAM 4th Edition firmly establishes "Co-Occurring Capable" as the baseline expectation for all addiction treatment.
Treating "Capable" tier care as a specialized commodity or a premium feature is functionally obsolete. If a facility cannot safely and effectively manage common, low-to-moderate acuity psychiatric symptoms concurrently with addiction, they are operating below the modern standard of care. For patients with severe, active psychiatric symptoms, programs must offer Co-Occurring Enhanced (COE) capabilities.
Recovery residences, carefully
The 4th Edition formally maps recovery residences (sober living) to clinical care. Standard recovery residences (NARR Types I, II, and III) provide a safe environment but are not clinical treatment. They are utilized in combination with outpatient levels of care (e.g., Level 2.1 + Recovery Residence).
Only Type IV (Clinical Recovery Residences / Type C) feature embedded clinical programming recognized as equivalent to an ASAM Level 3.1 placement. Families must be vigilant when facilities market standard sober living as if it were a clinical residential tier.
How to use the Criteria to advocate
If you're the patient or family
- Ask for the Dimensional Drivers. Demand to know exactly which dimensions are justifying the recommended level of care.
- Verify baseline capability. Confirm that the program operates at the Co-Occurring Capable or Co-Occurring Enhanced tier.
- Check the medication policy. Ensure the facility supports all FDA-approved addiction medications without requiring tapers.
- Demand treatment-day rationale. Ensure length of stay is anchored to clinical benchmarks and actual treatment days, not predetermined calendar limits.
If you're fighting a payer denial
Federal parity law (MHPAEA) requires commercial payers to utilize generally accepted standards of care, which widely points to the ASAM Criteria. If an insurance company issues a denial, you can strategically counter it:
- Request the utilization review criteria in writing. Compare their cited criteria directly against the ASAM 4th Edition standards for the disputed level of care.
- Obtain a dimensional letter of medical necessity. Have the treating clinician write a targeted appeal that explicitly links the patient's symptoms to the ASAM Dimensional Drivers.
- Exhaust internal appeals, then file externally. Utilize the external review process managed by your state's department of banking and insurance. Fact-based, dimensionally grounded appeals frequently overturn initial payer denials.
The underlying message
The ASAM Criteria remove the guesswork from addiction care placement. They transform "what kind of treatment?" from a marketing pitch into an audit-ready, clinical calculation rooted in six dimensions. When deployed accurately, they protect patients from dangerous under-treatment and prevent the systemic waste of over-treatment.
What to read next
- Ways to Avoid Rehab: The Evidence-Based Guide
- The ASAM Criteria (3rd Edition), Explained for Families
- How to Appeal an Insurance Denial for SUD Care (coming soon)
- What "Co-Occurring Capable" Actually Means (coming soon)
AvoidRehab Editorial Team
Clinically reviewed by licensed clinicians with expertise in substance use disorder. Last reviewed April 23, 2026.
Sources
What to read next
Most people with substance use disorders can be treated effectively without residential rehab. Outpatient care, medications, and harm reduction are real options backed by clinical evidence. You do not have to make a permanent decision today. The next step can be small.